1,790
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia

, , &
Pages 128-136 | Received 27 Feb 2023, Accepted 11 Oct 2023, Published online: 21 Nov 2023

References

  • Andlin-Sobocki P, Wittchen HU. Cost of anxiety disorders in Europe. Eur J Neurol. 2005;12(Suppl 1):39–44. doi:10.1111/j.1468-1331.2005.01196.x.
  • American Psychiatric Association. DSM-5 Task Force. Diagnostic and statistical manual of mental disorders [electronic resource]: DSM-5. 5th ed. Arlington (VA): American Psychiatric Association; 2013.
  • World Health Organization. International statistical classification of diseases and related health problems. 11th ed.; 2019. https://icd.who.int/.
  • Fredrikson M, Annas P, Fischer H, et al. Gender and age differences in the prevalence of specific fears and phobias. Behav Res Ther. 1996;34(1):33–39. doi:10.1016/0005-7967(95)00048-3.
  • Stinson FS, Dawson DA, Chou SP, et al. The epidemiology of DSM-IV specific phobia in the USA: results from the national epidemiologic survey on alcohol and related conditions. Psychol Med. 2007;37(7):1047–1059. doi:10.1017/S0033291707000086.
  • Eaton WW, Bienvenu OJ, Miloyan B. Specific phobias. Lancet Psychiatry. 2018;5(8):678–686. doi:10.1016/S2215-0366(18)30169-X.
  • Öst LG. One-session treatments for a case of multiple simple phobias. Cognit Behav Ther. 1987;16(4):175–184. doi:10.1080/16506078709455800.
  • Miloff A. 2020). Virtual reality exposure therapy for spider phobia [doctoral dissertation]. Stockholm: Department of Psychology, Stockholm University.
  • Wardenaar KJ, Lim CC, Al-Hamzawi AO, et al. The cross-national epidemiology of specific phobia in the world mental health surveys. Psychol Med. 2017;47(10):1744–1760. doi:10.1017/S0033291717000174.
  • Boeldt D, McMahon E, McFaul M, et al. Using virtual reality exposure therapy to enhance treatment of anxiety disorders: identifying areas of clinical adoption and potential obstacles. Front Psychiatry. 2019;10:773. doi:10.3389/fpsyt.2019.00773.
  • Pittig A, Kotter R, Hoyer J. The struggle of behavioral therapists with exposure: self-Reported practicability, negative beliefs, and therapist distress about Exposure-Based interventions. Behav Ther. 2019;50(2):353–366. doi:10.1016/j.beth.2018.07.003.
  • Benbow AA, Anderson PL. A meta-analytic examination of attrition in virtual reality exposure therapy for anxiety disorders. J Anxiety Disord. 2019;61:18–26. doi:10.1016/j.janxdis.2018.06.006.
  • Fernandez E, Salem D, Swift JK, et al. Meta-analysis of dropout from cognitive behavioral therapy: magnitude, timing, and moderators. J Consult Clin Psychol. 2015;83(6):1108–1122. doi:10.1037/ccp0000044.
  • Meyerbröker K, Emmelkamp PM. Therapeutic processes in virtual reality exposure therapy: the role of cognitions and the therapeutic alliance. J Cybertherapy Rehabil. 2008;1(3):247–257.
  • Freitas JRS, Velosa VHS, Abreu LTN, et al. Virtual reality exposure treatment in phobias: a systematic review. Psychiatr Q. 2021;92(4):1685–1710. doi:10.1007/s11126-021-09935-6.
  • Oing T, Prescott J. Implementations of virtual reality for Anxiety-Related disorders: systematic review. JMIR Serious Games. 2018;6(4):e10965. doi:10.2196/10965.
  • Brice D, Gibson Z, McGuinness F, et al. Using ultrasonic haptics within an immersive spider exposure environment to provide a multi-sensorial experience. Front Virtual Real. 2021;2:107. doi:10.3389/frvir.2021.707731.
  • Miloff A, Lindner P, Dafgård P, et al. Automated virtual reality exposure therapy for spider phobia vs. in-vivo one-session treatment: a randomized non-inferiority trial. Behav Res Ther. 2019;118:130–140. doi:10.1016/j.brat.2019.04.004.
  • Shiban Y, Pauli P, Mühlberger A. Effect of multiple context exposure on renewal in spider phobia. Behav Res Ther. 2013;51(2):68–74. doi:10.1016/j.brat.2012.10.007.
  • Tabbaa L, Ang CS, Siriaraya P, et al. A reflection on virtual reality design for psychological, cognitive and behavioral interventions: design needs, opportunities and challenges. Int J Hum–Comput Interact. 2021;37(9):851–866. doi:10.1080/10447318.2020.1848161.
  • Wechsler TF, Kümpers F, Mühlberger A. Inferiority or even superiority of virtual reality exposure therapy in phobias? A systematic review and quantitative meta-analysis on randomized controlled trials specifically comparing the efficacy of virtual reality exposure to gold standard in vivo exposure in agoraphobia, specific phobia, and social phobia. Front Psychol. 2019;10:1758. doi:10.3389/fpsyg.2019.01758.
  • Garcia-Palacios A, Botella C, Hoffman H, et al. Comparing acceptance and refusal rates of virtual reality exposure vs. in vivo exposure by patients with specific phobias. Cyberpsychol Behav. 2007;10(5):722–724. doi:10.1089/cpb.2007.9962.
  • Fredrikson M. Reliability and validity of some specific fear questionnaires. Scand J Psychol. 1983;24(4):331–334. doi:10.1111/j.1467-9450.1983.tb00507.x.
  • Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exercise Health. 2019;11(4):589–597. doi:10.1080/2159676X.2019.1628806.
  • Odgers K, Kershaw KA, Li SH, et al. The relative efficacy and efficiency of single-and multi-session exposure therapies for specific phobia: a meta-analysis. Behav Res Ther. 2022;159:104203. doi:10.1016/j.brat.2022.104203.
  • Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863. doi:10.3389/fpsyg.2013.00863.
  • Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59(1):12–19. doi:10.1037//0022-006x.59.1.12.
  • Carl E, Stein AT, Levihn-Coon A, et al. Virtual reality exposure therapy for anxiety and related disorders: a meta-analysis of randomized controlled trials. J Anxiety Disord. 2019;61:27–36. doi:10.1016/j.janxdis.2018.08.003.
  • Krzystanek M, Surma S, Stokrocka M, et al. Tips for effective implementation of virtual reality exposure therapy in phobias—a systematic review. Front Psychiatry. 2021;12:737351. doi:10.3389/fpsyt.2021.737351.
  • Krijn M, Emmelkamp PMG, Biemond R, et al. Treatment of acrophobia in virtual reality: the role of immersion and presence. Behav Res Ther. 2004;42(2):229–239. doi:10.1016/S0005-7967(03)00139-6.
  • Slater M, Sanchez-Vives MV. Enhancing our lives with immersive virtual reality. Front Robot AI. 2016;3:74. doi:10.3389/frobt.2016.00074.
  • Craske MG, Treanor M, Conway CC, et al. Maximizing exposure therapy: an inhibitory learning approach. Behav Res Ther. 2014;58:10–23. doi:10.1016/j.brat.2014.04.006.
  • Cheung AC, Slavin RE. How methodological features affect effect sizes in education. Educ Res. 2016;45(5):283–292. doi:10.3102/0013189X16656615.
  • Kraemer HC, Mintz J, Noda A, et al. Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry. 2006;63(5):484–489. doi:10.1001/archpsyc.63.5.484.
  • Cuijpers P, Reijnders M, Huibers MJ. The role of common factors in psychotherapy outcomes. Annu Rev Clin Psychol. 2019;15(1):207–231. doi:10.1146/annurev-clinpsy-050718-095424.
  • Bouchard S, Côté S, St-Jacques J, et al. Effectiveness of virtual reality exposure in the treatment of arachnophobia using 3D games. Technol Health Care. 2006;14(1):19–27. doi:10.3233/THC-2006-14103.
  • Minns S, Levihn-Coon A, Carl E, et al. Immersive 3D exposure-based treatment for spider fear: a randomized controlled trial. J Anxiety Disord. 2019;61:37–44.